|
| Status |
Public on Mar 03, 2012 |
| Title |
A549 |
| Sample type |
genomic |
| |
|
| Source name |
cell line
|
| Organism |
Homo sapiens |
| Characteristics |
cell type: NSCLC
em_status: M
response: intermediate
|
| Extracted molecule |
genomic DNA |
| Extraction protocol |
standard as recommended by illumina
|
| Label |
Cy3
|
| Label protocol |
standard as recommended by illumina
|
| |
|
| Hybridization protocol |
standard as recommended by illumina
|
| Scan protocol |
standard as recommended by illumina
|
| Description |
Non-small cell lung cancer cell line A549
|
| Data processing |
Preprocessed by Bioconductor lumi (v 2.5.3) package and sliding window smoothed with 250bp half-window-size.
|
| |
|
| Submission date |
Mar 01, 2012 |
| Last update date |
Mar 03, 2012 |
| Contact name |
David S Shames |
| E-mail(s) |
shames.david@gene.com
|
| Phone |
650-225-7559
|
| Organization name |
Genentech Inc
|
| Department |
Oncology Biomarker Development
|
| Lab |
Shames
|
| Street address |
1 DNA Way
|
| City |
South San Francisco |
| State/province |
CA |
| ZIP/Postal code |
94080 |
| Country |
USA |
| |
|
| Platform ID |
GPL13534 |
| Series (1) |
| GSE36216 |
DNA Methylation Profiling Defines Clinically Relevant Biological Subsets of Non-small Cell Lung Cancer |
|
